has already achieved significant results in diabetes treatment and weight management
Some will lose 20% of their weight and others only 5%
Metabolism & Elimination The metabolic fate of GLP3 has been partially characterized in clinical pharmacology studies[17]: Mean elimination half-life of approximately 6 days in healthy adults and patients with type 2 diabetes Hepatic metabolism represents the primary clearance pathway Does not interact with cytochrome P450 enzyme systems, minimizing potential drug-drug interactions Likely undergoes peptidase-mediated degradation and proteolytic cleavage The three non-coded amino acid modifications confer resistance to dipeptidyl peptidase-4, contributing to extended half-life The prolonged half-life enables once-weekly dosing while maintaining therapeutic drug concentrations throughout the dosing interval, with minimal peak-to-trough fluctuations that could contribute to side effects or reduced efficacy
Korner, M., Stockli, M., Waser, B
The long elimination half-life of 25-68 hours further supports convenient once-daily dosing
All product descriptions and articles provided on this website are intended strictly for informational and educational purposes
